U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C4H10O2S2
Molecular Weight 154.251
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DITHIOTHREITOL

SMILES

O[C@@H](CS)[C@@H](O)CS

InChI

InChIKey=VHJLVAABSRFDPM-IMJSIDKUSA-N
InChI=1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2/t3-,4-/m0/s1

HIDE SMILES / InChI

Description

Dithiothreitol is a chemical reagent with a wide actuation spectrum not only from a laboratorial view but also from a therapeutic standpoint, more clinical and practical. DTT (i) is frequently used in a variety of experiences that involve proteins or peptides, protecting sulfhydryl groups from oxidation and reducing disulfide bonds between cysteines; (ii) is also used in the study of disulfide exchange reactions of protein disulfides; (iii) is able to keep glutathione in the reduced state; (iv) acts as an "antidote" enabling the activity of detoxification systems; (v) participates in cellular mechanisms such as vesiculation, cell morphology, signal transduction pathways (hormone-'like' role), etc.; (vi) can be used in the treatment approach of diseases like cystinosis or medical conditions resulting from ion or metal toxicity. DTT is as a reducing or "deprotecting" agent. DTT protects notably enzyme activity loss by the oxidation of sulfhydryl groups. The DTT removal is performed by standard desalting.procedures (dialysis, gelfiltration). As an antioxidant, it is used as a protective agent against ionizing radiations in living cells. It has been used to enhance or inhibit enzymes or receptors activity.

CNS Activity

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
0.4 mM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
Rats were pretreated 20 min before NaSH injection with 100 mg/kg Dithiothreitol (DTI) (i.p.). The DTT dose used for rats was calculated from mouse LDs0 data using the differential ratio between mouse and rat sulfide LDs0 data (Reiffenstein and Warenycia 1987) as the comparison basis. A dose of 100 mg/kg Dql" was thus calculated by this method to be equivalent to an LD40.
Route of Administration: Intraperitoneal
In Vitro Use Guide
Treatment with 5 mM dithiothreitol significantly (P < 0.01) reduced the angiotensin II-induced contractile response to 1.2% in the rabbit aorta.